Literature DB >> 782703

Male breast cancer: a review.

F L Meyskens, D C Tormey, J P Neifeld.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1976        PMID： 782703     DOI： 10.1016/s0305-7372(76)80006-0

Source DB:  PubMed          Journal:  Cancer Treat Rev        ISSN： 0305-7372            Impact factor:   12.111


× No keyword cloud information.
  7 in total

1.  Y/6 chromosome translocation in a male with triple primary cancers involving the breast.

Authors:  A Kojima; T Ikeuchi; M Inomata; T Shinkai; K Ishihara; M Noguchi; N Saijo
Journal:  J Cancer Res Clin Oncol       Date:  1991       Impact factor: 4.553

2.  Male breast cancer: a clinicopathologic study of 97 cases.

Authors:  K S Heller; P P Rosen; D Schottenfeld; R Ashikari; D W Kinne
Journal:  Ann Surg       Date:  1978-07       Impact factor: 12.969

3.  Case-control study of occupational exposures and male breast cancer.

Authors:  P Cocco; L Figgs; M Dosemeci; R Hayes; M S Linet; A W Hsing
Journal:  Occup Environ Med       Date:  1998-09       Impact factor: 4.402

Review 4.  [Current status in the treatment of breast cancer. I. Endocrine management--change of concepts and outlook for the future (author's transl)].

Authors:  U Jehn; H Sauer; W Wilmanns
Journal:  Klin Wochenschr       Date:  1979-09-17

5.  Cancer of the male breast.

Authors:  J Axelsson; A Andersson
Journal:  World J Surg       Date:  1983-03       Impact factor: 3.352

6.  [Current status in the treatment of breast cancer. II. Adjuvant chemotherapy, palliative polychemotherapy, chemoimmunotherapy--rating and results (author's transl)].

Authors:  H Sauer; U Jehn; W Wilmanns
Journal:  Klin Wochenschr       Date:  1979-09-17

7.  Role of aminoglutethimide in male breast cancer.

Authors:  A L Harris; M Dowsett; R Stuart-Harris; I E Smith
Journal:  Br J Cancer       Date:  1986-10       Impact factor: 7.640
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.